Live Quote · NASDAQCNXUHealthcare· Biotechnology

Conexeu Sciences Inc.

$11.29 6.92%($-0.84)
TickerSpark Score

Limited financial coverage for CNXU.

Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.

30
Momentum
52-Week Range5% of range
Low
$10.87
Current
$11.29
High
$18.79
Company Overviewwww.conexeu.com

About the company

Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R.

CEO
Miles Harrison
IPO
2026
Employees
4
HQ
Reno, NV, US

Price Chart

-13.62% · this period
$16.85$14.07$11.29May 21Jun 03Jun 12
Performance & Tape
52W High
$18.79
52W Low
$10.87
50D MA
$13.93
200D MA
$13.93
Beta
0.00
Avg Volume
93.25K

Get TickerSpark's AI analysis on CNXU

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
May 26, 26Wright Michael G.other400,000
May 26, 26Wright Michael G.other400,000
May 11, 26Wright Michael G.other0
May 11, 26Wright Michael G.other0
Jun 9, 25Wright Michael G.other50,000
Jan 21, 25Wright Michael G.other78,595
May 11, 26Wright Michael G.other900,000
May 22, 26Sharpe Jeffrey Nathanother500,000
May 22, 26Sharpe Jeffrey Nathanother500,000
Coverage · CNXU

Our CNXU coverage

Recent articles, reports, and earnings notes.

View all →
For Active Investors

Want a deeper read on CNXU?

Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.

Generate CNXU report →